SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2004 / Cilt: 4 - Sayı: 1

Metabolic syndrome in patients after coronary bypass surgery: Prevalence and compliance with treatment

Koroner baypas sonrası hastalarda metabolik sendrom sıklığı ve tedaviye uyum oranları

Mustafa DEMİRTAŞ
Mehmet Emin KORKMAZ
Ahmet BİRAND
Semra TOPÇU
Mehmet BALTALI
Hidayet Tarık KIZILTAN
Şah TOPÇUOĞLU
Haldun MÜDERRİSOĞLU
Pages
10–16
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Rates for regular physical activity were lower in patients with MS, compared with those without MS (%36.9 vs. %47.7, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the prevalence of metabolic syndrome (MS) and its components, to determine the patients’ compliance with pharmacologic therapy and lifestyle modification, and to clarify the association of demographic and socioeconomic factors with the MS in Turkish patients with prior coronary artery bypass surgery (CABG).
📊
Key Findings & Data:Methods: Two hundred and seventy-three patients (age range 35-77, 208 men) were interviewed and examined 1.0-2.2 years after CABG.
💡
Conclusion & Impact:Rates for regular physical activity were lower in patients with MS, compared with those without MS (%36.9 vs. %47.7, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to evaluate the prevalence of metabolic syndrome (MS) and its components, to determine the patients’ compliance with pharmacologic therapy and lifestyle modification, and to clarify the association of demographic and socioeconomic factors with the MS in Turkish patients with prior coronary artery bypass surgery (CABG). Methods: Two hundred and seventy-three patients (age range 35-77, 208 men) were interviewed and examined 1.0-2.2 years after CABG. Results: The prevalence of MS was 44.8% (55.4% among women and 41.3% among men). The most prevalent metabolic risk factor was visceral obesity among females, and elevated blood pressure among males. Rates for regular physical activity were lower in patients with MS, compared with those without MS (%36.9 vs. %47.7, p

Özet

Amaç: Amacımız koroner baypas operasyonu sonrası hastalarda metabolik sendrom (MS) ve etmenlerinin sıklığını ortaya çıkartmak, önerilen yaşam tarzının ve farmakolojik tedavinin ne ölçüde uygulandığını tespit etmek, demografik ve sosyoekonomik faktörlerin MS varlığı ile ilişkisini irdelemektir. Yöntemler: Adana’da koroner baypas operasyonu geçirmiş 35 ile 77 yaş arası 273 hasta (208 erkek) ameliyattan 1.0 – 2.2 yıl sonra sorgulanıp, muayeneleri yapıldı ve kan örnekleri alındı. Bulgular: Hastalarda MS sıklığı %44.8 (kadınlarda %55.4 ve erkeklerde %41.3) idi. Kadınlarda santral obezite erkeklerde ise yüksek kan basıncı en sık görülen MS unsurları idiler. Metabolik sendrom mevcut hastalar, MS bulunmayanlara göre daha az sıklıkta düzenli egzersiz yaptıklarını ifade ettiler (%36.9 ile %47.7; p=0.03). Metabolik sendrom bulunan hastalar, diğer gruba göre daha az sıklıkta aspirin kullanıyor idi (sırasıyla %84.4 ile %93.4, p

🔖

Cite This Article

DEMİRTAŞ, M., KORKMAZ, M. E., BİRAND, A., TOPÇU, S., BALTALI, M., KIZILTAN, H. T., TOPÇUOĞLU, Ş., MÜDERRİSOĞLU, H. (2022). Metabolic syndrome in patients after coronary bypass surgery: Prevalence and compliance with treatment. Anadolu Kardiyoloji Dergisi, Cilt: 4 - Sayı: 1, 10–16. https://ajindex.com/articles/437463

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998, 81:(suppl):18B-25B
  2. Genest J JR, Cohn JS. Clustering of cardiovascular risk factors: targeting high-risk individuals. Am J Cardiol 1995, 76:8A-20A. 3.Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML.Impact of multiple risk factor profiles on determining cardiovascular disease risk.Prev Med 1998;27:1-9
  3. Sprecher DL, Pearce GL. How deadly is the “deadly quartet”?: a post-CABG evaluation. J Am Coll Cardiol 2000; 36:1159-65
  4. National Cholesterol Education. Adult Treatment Panel III. Bedhesda, MD: NIH Publ. 2001: 99 pages. No. 01 –3670
  5. Onat A, Sansoy V. Halkımızda koroner hastalığın baş suçlusu metabolik sendrom: sıklığı, unsurları, koroner risk ile ilişkisi ve yüksek risk kriterleri. Türk Kardiyol Dern Arş 2002;30:8-15
  6. Onat A, Büyüköztürk K, Sansoy V, ve ark. TKD koroner kalp hastalığı korunma ve tedavi kılavuzu Türk Kardiol Dern Arş 2002;30:568-94
  7. Sesso HD, Paffenbarger RS, Lee I. Physical activity and coronary heart disease in men: the Harvard Alumni Health Study. Circulation 2000;102:975-80
  8. Leon AS, Connett J. Physical activity and 10.5 year mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Int J Epidemiol 1991;5:67-72
  9. Thompson PD. The benefits and risks of exercise training in patients with chronic coronary artery disease. JAMA 1988;259:1537-40
  10. Manson J, Willett W, Stampfer M, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85
  11. Baltalı M, Kızıltan HT, Korkmaz ME, et al. Prevalence of modifiable cardiovascular risk factors remain high after coronary bypass graft surgery: a multicentre study among Turkish patients. J Cardiovascular Risk 2002;9:207-14
  12. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9
  13. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16
  14. Bonora E, Kiechl S, Willeit J, et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 2003;27:1283-9
  15. Milani RV, Lavie CJ. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation.